RedHill Biopharma Ltd.RDHLNASDAQ
Loading
P/E Ratio: Premium ValuationElevated
Percentile Rank86
Year-over-Year Change
Price-to-earnings ratio
Latest
-1.85
↑ 65% vs avg
Percentile
P86
Within normal range
Streak
1 yr
Consecutive declineElevated
Average
-5.33
Historical baseline
| Period | Value | YoY Change |
|---|---|---|
| 2024 | -1.85 | -334.0% |
| 2023 | 0.79 | +426.2% |
| 2022 | -0.24 | +90.1% |
| 2021 | -2.46 | +68.2% |
| 2020 | -7.73 | +9.3% |
| 2019 | -8.52 | -28.9% |
| 2018 | -6.61 | -66.2% |
| 2017 | -3.98 | +56.5% |
| 2016 | -9.15 | +32.4% |
| 2015 | -13.53 | - |